Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 5/2016

01-05-2016 | Progress in Hematology

Guest editorial: Institute of Hematology and Blood Diseases Hospital in China

Author: Hideo Ema

Published in: International Journal of Hematology | Issue 5/2016

Login to get access

Excerpt

In recent years, the contributions of Chinese scientists have played indispensable roles in the development of scientific knowledge and development of novel technologies. Research funding in China provided by the central and local governments has kept pace with economic growth, and the number of scientific publications from China has increased significantly in the past decade. Many talented young people are interested not only in practicing medicine, but also in advancing medical science, and many such investigators also wish to remain in China to conduct their own scientific research. …
Metadata
Title
Guest editorial: Institute of Hematology and Blood Diseases Hospital in China
Author
Hideo Ema
Publication date
01-05-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-1967-5

Other articles of this Issue 5/2016

International Journal of Hematology 5/2016 Go to the issue

Erratum

Erratum to: Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

Images in Hematology

Signet ring cell “lymphoma”: mimicking the appearance of signet ring cell carcinoma

Original Article

In vitro alteration of hematological parameters and blood viscosity by the perfluorocarbon: Oxycyte

Images in Hematology

Megaloblastic anemia presenting with skin hyperpigmentation

Progress in Hematology

Mechanisms of self-renewal in hematopoietic stem cells

Original Article

The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits